Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery

Alzheimer’s disease (AD) is the leading cause of dementia, affecting approximately 33.5 million people worldwide. Aging is the main risk factor associated with AD. Drug discovery based on nutraceutical molecules for prevention and treatment of AD is a growing topic. In this sense, carotenoids are ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakey-Beitia, Johant, Doens, Deborah, Jagadeesh Kumar, D, Murillo, Enrique, Fernandez, Patricia L, Rao, KS, Durant-Archibold, Armando A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440000/
https://www.ncbi.nlm.nih.gov/pubmed/28553090
http://dx.doi.org/10.2147/CIA.S134605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440000/
https://www.ncbi.nlm.nih.gov/pubmed/28553090
http://dx.doi.org/10.2147/CIA.S134605

Ejemplares similares